Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 10/20 | 0.48 |
| ▸ | JAK2 | O60674 | 7/20 | 0.48 |
| ▸ | JAK1 | P23458 | 6/20 | 0.48 |
| ▸ | JAK3 | P52333 | 6/20 | 0.48 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 4/20 | 0.38 |
| ▸ | MAP4K1 | Q92918 | 3/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18409136 | 0.94 | TYK2 (0.46) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18409582 | 0.92 | JAK2 (0.43) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18408930 | 0.91 | LRRK2 (0.44) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18408928 | 0.90 | TYK2 (0.46) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18409454 | 0.90 | TYK2 (0.41) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18409158 | 0.90 | TYK2 (0.58) | TYK2JAK2JAK1JAK3ABL1 | |
| SCHEMBL18409137 | 0.89 | LRRK2 (0.44) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18398513 | 0.87 | TYK2 (0.62) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18409549 | 0.87 | TYK2 (0.62) | TYK2JAK2JAK1JAK3LRRK2 | |
| SCHEMBL18409160 | 0.87 | JAK2 (0.51) | TYK2JAK2JAK1JAK3LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017012647-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | GALAPAGOS NV (BE) | 2017-01-26 | — | — | WO | disclosed |